Medical Database’s proprietary platform offers reliable and updated laboratory test data to easily assist providers, payers, and diagnostic centers in ordering appropriate clinical test to meet medical necessity and maintain compliance.
The company’s proprietary (patent pending) ranking system provides users with the most relevant diagnostic test based on either diagnosis and/or ICD10 codes. The evidence-based content comprises a range of medical databases and uses a unique algorithm to assist in making appropriate diagnosis decisions.
The Laboratory Decision Support (LDS) platform utilizes this ranking system to score potential tests for any given disease and assigns an easily interpretable numerical and color-coded score that is visible next to the individual test. The colors and numbers indicate the most relevant test to meet medical necessity. Green and the number 10 represent the highest level of relevance.
“More than 5 billion diagnostic tests are performed in the U.S. each year,” said Safedin Sajo Beqaj, PhD, CEO of Medical Database, Inc. “Selecting the most appropriate laboratory test has been proven to reduce costs and improve outcomes for both healthcare providers as well as patients. The LDS platform, which incorporates every lab test available in the market including genetic testing, together with all applicable codes, offers an invaluable resource to achieve that goal.”
Tests can be ordered randomly by assay, CPT code, disease, or ICD10 code. Each time an order is placed via the LDS platform, it automatically includes the appropriate diagnostic ICD10 code to meet medical necessity for payment. This innovative feature allows labs and providers to use the LDS platform to streamline claims submission/verification and, thereby, improve reimbursement and increase revenue.
Medical Database will be showcasing its LDS and LDS Analytics platform at the AACC show in Booth #3678.
